Antibody responses against heterologous H5N1 strains for an MF59-adjuvanted cell culture–derived H5N1 (aH5n1c) influenza vaccine in adults and older adults

MF59-adjuvanted H5N1, cell culture-derived inactivated influenza vaccine (aH5N1c, AUDENZ®, Seqirus) is available for persons 6 months of age and older. During a pandemic, lack of preexisting immunity to novel influenza strains increases morbidity and mortality. This study examined the potential for...

Descripción completa

Detalles Bibliográficos
Autores principales: Frey, Sharon S., Versage, Eve, Van Twuijver, Esther, Hohenboken, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Influenza
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114991/
https://www.ncbi.nlm.nih.gov/pubmed/37057755
http://dx.doi.org/10.1080/21645515.2023.2193119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114991/
https://www.ncbi.nlm.nih.gov/pubmed/37057755
http://dx.doi.org/10.1080/21645515.2023.2193119

Ejemplares similares